Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk‐stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172)

Frank G. H. Hill(Children's of Alabama), Osborn B. Eden, Christopher Mitchell(John Radcliffe Hospital), Sue Richards(Oregon Health & Science University), Brenda Gibson(Royal Hospital for Children), John Lilleyman(Royal London Hospital), Christine J. Harrison(Newcastle University), Ian Hann(Royal Hospital for Children), Sally E. Kinsey(St James's University Hospital)
British Journal of Haematology
December 11, 2003
10.1046/j.1365-2141.2003.04738.x
Cited by 80

Related Papers

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
|Blood|2006|746
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
|Blood|2009|494
Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial
|Journal of Clinical Oncology|2013|415
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383